Find the latest clinical trials by condition, location & phase
Browse and search for drug information and related clinical trials
Explore a comprehensive list of organizations, including their profiles and details.
Latest updates on clinical trials, pharmaceuticals, and healthcare companies
Stay informed with timely notifications on clinical trials and research advancements.
No overview information available.
No background information available.
No indication information available.
No associated conditions information available.
Cytokinetics has commenced enrollment for the AMBER-HFpEF Phase 2 trial to assess CK-586 in patients with symptomatic heart failure with preserved ejection fraction (HFpEF).
Cytokinetics submitted a New Drug Application (NDA) to the FDA for aficamten in Q3, marking a significant step toward potential U.S. approval.